Skip to main content
Article
Unbiased Assessment of H-STS cells as high-fidelity models for gastro-enteropancreatic neuroendocrine tumor drug mechanism of action analysis
bioRxiv (2019)
  • Mariano J. Alvarez, Columbia University
  • Pengrong Yan, Memorial Sloan Kettering Cancer Center
  • Mary L. Alpaugh, Rowan University
  • Mary L. Alpaugh, Memorial Sloan Kettering Cancer Center
  • Michaela Bowden, Department of Translational Medicine
  • Ewa Sicinska, Harvard University
  • Chensheng W. Zhou, Harvard University
  • Charles Karan, Columbia University
  • Ronald B. Realubit, Columbia University
  • Prabhjot S. Mundi, Columbia University
  • Adina Grunn, Columbia University
  • Dirk Jäger, Heidelberg University
  • John A. Chabot, Columbia University
  • Antonio T. Fojo, Columbia University
  • Paul E. Oberstein, Department of Medical Oncology, Perlmutter Cancer Center
  • Hanina Hibshoosh, Columbia University
  • Jeffrey W. Milsom, Cornell University
  • Matthew H. Kulke, Boston University
  • Massimo Loda, Cornell University
  • Gabriela Chiosis, Memorial Sloan Kettering Cancer Center
  • Diane L. Reidy-Lagunes, Memorial Sloan Kettering Cancer Center
  • Andrea Califano, Department of Systems Biology, Columbia University Irvin Medical Center
Publication Date
June 23, 2019
DOI
10.1101/677435
Citation Information
Mariano J. Alvarez, Pengrong Yan, Mary L. Alpaugh, Mary L. Alpaugh, et al.. "Unbiased Assessment of H-STS cells as high-fidelity models for gastro-enteropancreatic neuroendocrine tumor drug mechanism of action analysis" bioRxiv (2019) p. 677435
Available at: http://works.bepress.com/mary-alpaugh/19/